-
2
-
-
0001875379
-
Drugs and the treatment of psychiatric disorders: Antipsychotic and antianxiety agents
-
Harden W, Rudin W, Molinoff PB, Rall T, eds. New York, NY: McGraw-Hill Book Co
-
Baldessarini RJ. Drugs and the treatment of psychiatric disorders: antipsychotic and antianxiety agents. In: Harden W, Rudin W, Molinoff PB, Rall T, eds. Goodman and Gilman's the Pharmacologic Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill Book Co; 1996:399-430.
-
(1996)
Goodman and Gilman's the Pharmacologic Basis of Therapeutics. 9th Ed.
, pp. 399-430
-
-
Baldessarini, R.J.1
-
3
-
-
0028916857
-
Neuroleptic withdrawal in schizophrenic patients: A review of the literature
-
Gilbert PL, Harris MJ, Jeste DV. Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Arch Gen Psychiatry. 1995;2:173-188.
-
(1995)
Arch Gen Psychiatry
, vol.2
, pp. 173-188
-
-
Gilbert, P.L.1
Harris, M.J.2
Jeste, D.V.3
-
4
-
-
0023873890
-
Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses
-
Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry. 1988;45:79-91.
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 79-91
-
-
Baldessarini, R.J.1
Cohen, B.M.2
Teicher, M.H.3
-
5
-
-
0026410773
-
Optimal dose of neuroleptic in acute schizophrenia: Controlled study of the neuroleptic threshold and higher haloperidol dose
-
McEvoy JP, Hogarty GE, Steingard S. Optimal dose of neuroleptic in acute schizophrenia: controlled study of the neuroleptic threshold and higher haloperidol dose. Arch Gen Psychiatry. 1991;48:739-745.
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 739-745
-
-
McEvoy, J.P.1
Hogarty, G.E.2
Steingard, S.3
-
6
-
-
0028046945
-
A double-blind dosage reduction trial of fluphenazine decanoate in chronic, unstable schizophrenic patients
-
Inderbitzen LB, Lewine RRJ, Scheller-Gilkey G, Swofford CD, Egan GJ, Gloersen BA, Vidanagama BP, Waternaux C. A double-blind dosage reduction trial of fluphenazine decanoate in chronic, unstable schizophrenic patients. Am J Psychiatry. 1994;151:1753-1759.
-
(1994)
Am J Psychiatry
, vol.151
, pp. 1753-1759
-
-
Inderbitzen, L.B.1
Lewine, R.R.J.2
Scheller-Gilkey, G.3
Swofford, C.D.4
Egan, G.J.5
Gloersen, B.A.6
Vidanagama, B.P.7
Waternaux, C.8
-
7
-
-
0028235820
-
Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients
-
Smith RC. Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients. Arch Gen Psychiatry. 1994;51:427-429.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 427-429
-
-
Smith, R.C.1
-
8
-
-
0025040951
-
Continuous vs targeted medication in schizophrenic outpatients: Outcome results
-
Carpenter WT, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, Buchanan RW. Continuous vs targeted medication in schizophrenic outpatients: outcome results. Am J Psychiatry. 1990;147:1138-1148.
-
(1990)
Am J Psychiatry
, vol.147
, pp. 1138-1148
-
-
Carpenter, W.T.1
Hanlon, T.E.2
Heinrichs, D.W.3
Summerfelt, A.T.4
Kirkpatrick, B.5
Levine, J.6
Buchanan, R.W.7
-
9
-
-
0025881660
-
Intermittent vs maintenance medication in schizophrenia: Two-year results
-
Herz MI, Glazer WM, Mostert MA, Sheard MA, Szymanski HV, Hafez H, Mirza M, Vana J. Intermittent vs maintenance medication in schizophrenia: two-year results. Arch Gen Psychiatry. 1991;48:333-339.
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 333-339
-
-
Herz, M.I.1
Glazer, W.M.2
Mostert, M.A.3
Sheard, M.A.4
Szymanski, H.V.5
Hafez, H.6
Mirza, M.7
Vana, J.8
-
10
-
-
0027322643
-
Continuous vs intermittent neuroleptic therapy in schizophrenia
-
Jolley AG, Hirsch SR. Continuous vs intermittent neuroleptic therapy in schizophrenia. Drug Saf. 1993;8:331-339.
-
(1993)
Drug Saf.
, vol.8
, pp. 331-339
-
-
Jolley, A.G.1
Hirsch, S.R.2
-
12
-
-
0002629884
-
Atypical antipsychotic drugs
-
Bloom FE, Kupfer DJ, eds. New York, NY: Raven Press
-
Meltzer HY. Atypical antipsychotic drugs. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the Fourth Generation of Progress. New York, NY: Raven Press; 1995:1277-1286.
-
(1995)
Psychopharmacology: the Fourth Generation of Progress
, pp. 1277-1286
-
-
Meltzer, H.Y.1
-
13
-
-
0028070548
-
The continuing unethical use of placebo controls
-
Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med. 1994;331:294-298.
-
(1994)
N Engl J Med
, vol.331
, pp. 294-298
-
-
Rothman, K.J.1
Michels, K.B.2
-
14
-
-
0028913007
-
Use of placebo controls in clinical trials disputed
-
Taubes G. Use of placebo controls in clinical trials disputed. Science. 1995;267:25-26.
-
(1995)
Science
, vol.267
, pp. 25-26
-
-
Taubes, G.1
-
15
-
-
0029264053
-
Neuroleptic withdrawal in schizophrenic patients
-
Baldessarini RJ, Viguera AC. Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry. 1995;52:189-192.
-
(1995)
Arch Gen Psychiatry
, vol.52
, pp. 189-192
-
-
Baldessarini, R.J.1
Viguera, A.C.2
-
16
-
-
0029270038
-
Considering neuroleptic maintenance and taper on a continuum: Need for individual rather than dogmatic approach
-
Jeste DV, Gilbert PL, McAdams LA, Harris MJ. Considering neuroleptic maintenance and taper on a continuum: need for individual rather than dogmatic approach. Arch Gen Psychiatry. 1995;52:209-212.
-
(1995)
Arch Gen Psychiatry
, vol.52
, pp. 209-212
-
-
Jeste, D.V.1
Gilbert, P.L.2
McAdams, L.A.3
Harris, M.J.4
-
17
-
-
0029774562
-
Lithium withdrawal in bipolar disorder: Implications for clinical practice and experimental therapeutics research
-
Baldessarini RJ, Suppes T, Tondo L. Lithium withdrawal in bipolar disorder: implications for clinical practice and experimental therapeutics research. Am J Ther. 1996;3:492-496.
-
(1996)
Am J Ther.
, vol.3
, pp. 492-496
-
-
Baldessarini, R.J.1
Suppes, T.2
Tondo, L.3
-
18
-
-
0002715423
-
Benzodiazepines: A risk-benefit profile
-
Lader M. Benzodiazepines: a risk-benefit profile. CNS Drugs. 1994;1:377-387.
-
(1994)
CNS Drugs
, vol.1
, pp. 377-387
-
-
Lader, M.1
-
19
-
-
0025057283
-
Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena
-
Dilsaver SC. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:137-161.
-
(1990)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.14
, pp. 137-161
-
-
Dilsaver, S.C.1
-
20
-
-
0026339062
-
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder
-
Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991;48:1082-1088.
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 1082-1088
-
-
Suppes, T.1
Baldessarini, R.J.2
Faedda, G.L.3
Tohen, M.4
-
21
-
-
0027156096
-
Outcome after rapid vs gradual discontinuation of lithium in bipolar mood disorders
-
Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs gradual discontinuation of lithium in bipolar mood disorders. Arch Gen Psychiatry. 1993;50:448-455.
-
(1993)
Arch Gen Psychiatry
, vol.50
, pp. 448-455
-
-
Faedda, G.L.1
Tondo, L.2
Baldessarini, R.J.3
Suppes, T.4
Tohen, M.5
-
22
-
-
0027671131
-
Discontinuing maintenance treatment in bipolar manic-depression: Risks and implications
-
Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. Discontinuing maintenance treatment in bipolar manic-depression: risks and implications. Harvard Rev Psychiatry. 1993;1:131-144.
-
(1993)
Harvard Rev Psychiatry
, vol.1
, pp. 131-144
-
-
Suppes, T.1
Baldessarini, R.J.2
Faedda, G.L.3
Tondo, L.4
Tohen, M.5
-
23
-
-
0026786588
-
Five-year outcome for maintenance therapies in recurrent depression
-
Kupfer DJ, Frank E, Perel JM, Comes C, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1992;49:769-773.
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 769-773
-
-
Kupfer, D.J.1
Frank, E.2
Perel, J.M.3
Comes, C.4
Mallinger, A.G.5
Thase, M.E.6
McEachran, A.B.7
Grochocinski, V.J.8
-
24
-
-
0029845056
-
Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders
-
Baldessarini RJ, Tondo L, Faedda G, Floris G, Suppes T, Rudas N. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry. 1996;57:441-448.
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 441-448
-
-
Baldessarini, R.J.1
Tondo, L.2
Faedda, G.3
Floris, G.4
Suppes, T.5
Rudas, N.6
-
25
-
-
15644384246
-
Sudden removal of tranquilizing drugs from chronic psychiatric patients
-
Olson GW, Peterson DB. Sudden removal of tranquilizing drugs from chronic psychiatric patients. J Nerv Ment Dis. 1960;131:252-255.
-
(1960)
J Nerv Ment Dis.
, vol.131
, pp. 252-255
-
-
Olson, G.W.1
Peterson, D.B.2
-
26
-
-
0342412947
-
Withdrawal of perphenazine in chronic schizophrenia
-
Whittaker CB, Hoy RM. Withdrawal of perphenazine in chronic schizophrenia. Br J Psychiatry. 1963;109:422-427.
-
(1963)
Br J Psychiatry
, vol.109
, pp. 422-427
-
-
Whittaker, C.B.1
Hoy, R.M.2
-
27
-
-
0000935644
-
Discontinuation or reduction of chemotherapy in chronic schizophrenics
-
Caffey EM, Diamond LS, Frank TV, Grasberger JC, Herman L, Klett CJ, Rothstein C. Discontinuation or reduction of chemotherapy in chronic schizophrenics. J Chronic Dis. 1964;17:347-358.
-
(1964)
J Chronic Dis.
, vol.17
, pp. 347-358
-
-
Caffey, E.M.1
Diamond, L.S.2
Frank, T.V.3
Grasberger, J.C.4
Herman, L.5
Klett, C.J.6
Rothstein, C.7
-
28
-
-
0013942220
-
Differential effects of abrupt vs gradual withdrawal of chlorpromazine in hospitalized schizophrenic patients
-
Greenberg LM, Roth S. Differential effects of abrupt vs gradual withdrawal of chlorpromazine in hospitalized schizophrenic patients. Am J Psychiatry. 1966;123:221-226.
-
(1966)
Am J Psychiatry
, vol.123
, pp. 221-226
-
-
Greenberg, L.M.1
Roth, S.2
-
29
-
-
0014039972
-
Phenothiazines in prevention of psychiatric hospitalization: Delay or prevention of hospitalization, a reevaluation
-
Engelhardt DM, Rosen B, Freedman N, Margolis R. Phenothiazines in prevention of psychiatric hospitalization: delay or prevention of hospitalization, a reevaluation. Arch Gen Psychiatry. 1967;16:98-101.
-
(1967)
Arch Gen Psychiatry
, vol.16
, pp. 98-101
-
-
Engelhardt, D.M.1
Rosen, B.2
Freedman, N.3
Margolis, R.4
-
30
-
-
0014530745
-
Relapse in chronic schizophrenics following abrupt withdrawal of tranquilizing medication
-
Prien RF, Cole JO, Belkin NF. Relapse in chronic schizophrenics following abrupt withdrawal of tranquilizing medication. Br J Psychiatry. 1969;115:679-686.
-
(1969)
Br J Psychiatry
, vol.115
, pp. 679-686
-
-
Prien, R.F.1
Cole, J.O.2
Belkin, N.F.3
-
31
-
-
84970838697
-
Trial of maintenance therapy in schizophrenia
-
Leff JP, Wing JK. Trial of maintenance therapy in schizophrenia, Br J Psychiatry. 1971;11:599-604.
-
(1971)
Br J Psychiatry
, vol.11
, pp. 599-604
-
-
Leff, J.P.1
Wing, J.K.2
-
32
-
-
0016199194
-
Drug and sociotherapy in the aftercare of schizophrenic patients: Two-year relapse rate
-
Hogarty GE, Goldberg SC, Schooler NR, Ulrich RF. Drug and sociotherapy in the aftercare of schizophrenic patients: two-year relapse rate. Arch Gen Psychiatry. 1974;31:603-608.
-
(1974)
Arch Gen Psychiatry
, vol.31
, pp. 603-608
-
-
Hogarty, G.E.1
Goldberg, S.C.2
Schooler, N.R.3
Ulrich, R.F.4
-
33
-
-
0016658036
-
Pimozide in chronic schizophrenic outpatients
-
Clark ML, Huber WK, Hill D, Wood F, Costiloe JP. Pimozide in chronic schizophrenic outpatients. Dis Nerv Syst. 1975;36:137-141.
-
(1975)
Dis Nerv Syst.
, vol.36
, pp. 137-141
-
-
Clark, M.L.1
Huber, W.K.2
Hill, D.3
Wood, F.4
Costiloe, J.P.5
-
34
-
-
0018894038
-
Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication
-
Levine J, Schooler NR, Severe J, Escobar J, Gelenberg AJ, Mandel M, Sovner R, Steinbook R. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication. Adv Biochem Psychopharmacol. 1980;24:483-495.
-
(1980)
Adv Biochem Psychopharmacol
, vol.24
, pp. 483-495
-
-
Levine, J.1
Schooler, N.R.2
Severe, J.3
Escobar, J.4
Gelenberg, A.J.5
Mandel, M.6
Sovner, R.7
Steinbook, R.8
-
35
-
-
0019419898
-
Schizophrenics fully remitted on neuroleptics for 3-5 years - to stop or continue drugs?
-
Cheung HK. Schizophrenics fully remitted on neuroleptics for 3-5 years - to stop or continue drugs? Br J Psychiatry. 1981;138:490-494.
-
(1981)
Br J Psychiatry
, vol.138
, pp. 490-494
-
-
Cheung, H.K.1
-
36
-
-
0028265095
-
Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia
-
van Kammen DP, Agren H, Yao JK, O'Connor DT, Gurklis J, Peters JL. Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. Am J Psychiatry. 1994;51:379-384.
-
(1994)
Am J Psychiatry
, vol.51
, pp. 379-384
-
-
Van Kammen, D.P.1
Agren, H.2
Yao, J.K.3
O'Connor, D.T.4
Gurklis, J.5
Peters, J.L.6
-
37
-
-
0029874893
-
Predicting duration of clinical stability following haloperidol withdrawal in schizophrenia
-
In press
-
van Kammen DP, Kelley ME, Gurklis JA, Gilbertson MW, Yao JK, Condray R, Peters JL. Predicting duration of clinical stability following haloperidol withdrawal in schizophrenia. Neuropsychopharmacology. In press.
-
Neuropsychopharmacology
-
-
Van Kammen, D.P.1
Kelley, M.E.2
Gurklis, J.A.3
Gilbertson, M.W.4
Yao, J.K.5
Condray, R.6
Peters, J.L.7
-
38
-
-
0019474555
-
Effects of neuroleptic adjustment on clinical condition in tardive dyskinesia in schizophrenic patients
-
Branchey MH, Branchey LB, Richardson MA. Effects of neuroleptic adjustment on clinical condition in tardive dyskinesia In schizophrenic patients. Am J Psychiatry. 1981;138:608-612.
-
(1981)
Am J Psychiatry
, vol.138
, pp. 608-612
-
-
Branchey, M.H.1
Branchey, L.B.2
Richardson, M.A.3
-
40
-
-
0018846798
-
Do schizophrenics well adapted in the community need neuroleptics? a depot withdrawal study
-
Dencker SJ, Lepp M, Malm U. Do schizophrenics well adapted in the community need neuroleptics? a depot withdrawal study. Acta Psychiatr Scand. 1980;61(suppl 279):64-76.
-
(1980)
Acta Psychiatr Scand
, vol.61
, Issue.SUPPL. 279
, pp. 64-76
-
-
Dencker, S.J.1
Lepp, M.2
Malm, U.3
-
41
-
-
0019512265
-
A depot neuroleptic withdrawal study: A controlled study of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients
-
Wistedt B. A depot neuroleptic withdrawal study: a controlled study of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients. Acta Psychiatr Scand. 1981;64:65-84.
-
(1981)
Acta Psychiatr Scand
, vol.64
, pp. 65-84
-
-
Wistedt, B.1
-
42
-
-
0026497409
-
Discontinuation in the very stable schizophrenic patient: Relapse rates and serum neuroleptic levels
-
Sampath G, Shah A, Krska J, Soni SD. Discontinuation in the very stable schizophrenic patient: relapse rates and serum neuroleptic levels. Hum Psychopharmacol. 1992;7:255-264.
-
(1992)
Hum Psychopharmacol
, vol.7
, pp. 255-264
-
-
Sampath, G.1
Shah, A.2
Krska, J.3
Soni, S.D.4
-
43
-
-
0000336139
-
Regression models and life tables
-
Cox DR. Regression models and life tables. J R Stat Soc Ser B. 1972;34:187-220.
-
(1972)
J R Stat Soc Ser B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
45
-
-
0028022630
-
One hundred years of schizophrenia: A meta-analysis of the outcome literature
-
Hegarty JD, Baldessarini RJ, Tohen M, Waternaux CM, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry. 1994;151:1409-1416.
-
(1994)
Am J Psychiatry
, vol.151
, pp. 1409-1416
-
-
Hegarty, J.D.1
Baldessarini, R.J.2
Tohen, M.3
Waternaux, C.M.4
Oepen, G.5
-
47
-
-
0026755250
-
The natural course of schizophrenia: A review of first-admission studies
-
Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE. The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull. 1992;18:185-207.
-
(1992)
Schizophr Bull.
, vol.18
, pp. 185-207
-
-
Ram, R.1
Bromet, E.J.2
Eaton, W.W.3
Pato, C.4
Schwartz, J.E.5
-
48
-
-
0026625429
-
Differences between antipsychotic drugs in persistence of brain levels and behavioral effects
-
Cohen BM, Tsuneizumi T, Baldessarini RJ, Campbell A, Babb S. Differences between antipsychotic drugs in persistence of brain levels and behavioral effects. Psychopharmacology (Berl). 1992;108:338-344.
-
(1992)
Psychopharmacology (Berl)
, vol.108
, pp. 338-344
-
-
Cohen, B.M.1
Tsuneizumi, T.2
Baldessarini, R.J.3
Campbell, A.4
Babb, S.5
-
49
-
-
0018651504
-
Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia
-
Baldessarini RJ, Tarsy D. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. Int Rev Neurobiol. 1979;21:1-45.
-
(1979)
Int Rev Neurobiol.
, vol.21
, pp. 1-45
-
-
Baldessarini, R.J.1
Tarsy, D.2
-
50
-
-
0018221504
-
Dopaminergic supersensitivity after neuroleptics: Time-course and specificity
-
Müller P, Seeman P. Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology (Berl). 1978;60:1-11.
-
(1978)
Psychopharmacology (Berl)
, vol.60
, pp. 1-11
-
-
Müller, P.1
Seeman, P.2
-
51
-
-
0026002768
-
Minimal effective dose and relapse - Double-blind trial: Haloperidol decanoate vs placebo
-
Eklund K, Forsman A. Minimal effective dose and relapse - double-blind trial: haloperidol decanoate vs placebo. Clin Neuropharmacol. 1991;14(suppl 2):S7-S17.
-
(1991)
Clin Neuropharmacol
, vol.14
, Issue.SUPPL. 2
-
-
Eklund, K.1
Forsman, A.2
-
53
-
-
0028148794
-
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia
-
Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM. Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology. 1994;11:107-118.
-
(1994)
Neuropsychopharmacology
, vol.11
, pp. 107-118
-
-
Lieberman, J.A.1
Alvir, J.2
Geisler, S.3
Ramos-Lorenzi, J.4
Woerner, M.5
Novacenko, H.6
Cooper, T.7
Kane, J.M.8
-
54
-
-
0026031035
-
Recent advances in the treatment of acute mania
-
Chou J C-Y. Recent advances in the treatment of acute mania. J Clin Psychopharmacol. 1991;11:3-21.
-
(1991)
J Clin Psychopharmacol
, vol.11
, pp. 3-21
-
-
Chou, J.C.-Y.1
-
55
-
-
0027139769
-
Chronic neuroleptic use in manic depressive illness
-
Sernyk MJ, Woods SW. Chronic neuroleptic use in manic depressive illness. Psychopharmacol Bull. 1993;29:375-381.
-
(1993)
Psychopharmacol Bull.
, vol.29
, pp. 375-381
-
-
Sernyk, M.J.1
Woods, S.W.2
|